Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04775745
Title Study of Oral Administration of LP-168 in Patients With Relapsed or Refractory B-cell Malignancies.
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Newave Pharmaceutical Inc
Indications

Waldenstroem's macroglobulinemia

B-cell lymphoma

chronic lymphocytic leukemia/small lymphocytic lymphoma

chronic lymphocytic leukemia

diffuse large B-cell lymphoma

follicular lymphoma

hairy cell leukemia

marginal zone B-cell lymphoma

Therapies

LP-168

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.